5-fluorouracil and allopurinol combined with recombinant interferon-alpha 2b in the treatment of patients with advanced prostate cancer: a phase I/II study.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 8558676)

Published in J Urol on February 01, 1996

Authors

D B Glazier1, J A Heaney, R J Amdur, A R Schned, R Harris, I Fukui, M S Ernstoff

Author Affiliations

1: Department of Urology, Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center, Lebanon, New Hampshire 03756-0001, USA.

Articles by these authors

Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet (1980) 10.23

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol (1996) 9.68

Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst (1993) 6.02

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol (1999) 5.95

Rapid preparation of lymphocytes for tissue-typing. Lancet (1969) 5.11

High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. J Clin Oncol (2001) 4.84

The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA (1999) 4.80

Clinical features and natural history of von Hippel-Lindau disease. Q J Med (1990) 4.71

High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol (2000) 4.60

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol (1992) 4.48

Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet (1983) 4.02

Cystic fibrosis carrier testing in early pregnancy by general practitioners. BMJ (1993) 3.85

Quantum annealing with manufactured spins. Nature (2011) 3.81

Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature (1992) 3.63

A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet (1992) 3.63

Videotape-based decision aid for colon cancer screening. A randomized, controlled trial. Ann Intern Med (2000) 3.61

Von Hippel-Lindau disease: a genetic study. J Med Genet (1991) 3.61

Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child (1981) 3.45

Informed choice in genetic screening for thalassaemia during pregnancy: audit from a national confidential inquiry. BMJ (2000) 3.38

A clinical study of type 2 neurofibromatosis. Q J Med (1992) 3.23

Apparent prevention of neural tube defects by periconceptional vitamin supplementation. 1981. Int J Epidemiol (2011) 2.68

Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med (1997) 2.67

Factors associated with the starting of cigarette smoking by primary school children. Br J Prev Soc Med (1974) 2.61

Comparison of pregnancy outcome after amniocentesis for previous neural tube defect or raised maternal serum alphafetoprotein. Br J Obstet Gynaecol (1980) 2.50

Uptake of presymptomatic predictive testing for Huntington's disease. Lancet (1989) 2.49

Tissue typing using a routine one-step lymphocyte separation procedure. Br J Haematol (1970) 2.48

Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor. J Clin Oncol (2000) 2.37

Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam. Brain (1977) 2.23

Recent skin self-examination and doctor visits in relation to melanoma risk and tumour depth. Br J Dermatol (2012) 2.20

Stability of choices about life-sustaining treatments. Ann Intern Med (1994) 2.20

Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood (1996) 2.19

Cystic fibrosis carrier screening at first diagnosis of pregnancy in general practice. Lancet (1992) 2.16

Are patients of women physicians screened more aggressively? A prospective study of physician gender and screening. J Gen Intern Med (1995) 2.16

Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients. Aliment Pharmacol Ther (2014) 2.11

Primary care for patients at genetic risk. BMJ (1995) 2.10

A report on genetic registers. Based on the report of the Clinical Genetics Society Working Party. J Med Genet (1978) 2.09

Substitution of a nursing-led inpatient unit for acute services: randomized controlled trial of outcomes and cost of nursing-led intermediate care. Age Ageing (2001) 2.07

Measuring the use of mammography: two methods compared. Am J Public Health (1992) 2.07

Tissue-shrinkage correction factor in the calculation of prostate cancer volume. Am J Surg Pathol (1996) 2.06

The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer. Cancer Res (2001) 2.06

Patient preferences for colon cancer screening. J Gen Intern Med (1999) 2.03

Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet (2000) 1.98

A cross-language study of prosodic modifications in mothers' and fathers' speech to preverbal infants. J Child Lang (1989) 1.94

Freeze-substitution of gram-negative eubacteria: general cell morphology and envelope profiles. J Bacteriol (1991) 1.92

A comprehensive quality assessment program on the autopsy service. Am J Clin Pathol (1986) 1.86

Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations. Arthritis Rheum (1978) 1.83

Ethics of predictive testing for Huntington's chorea: the need for more information. Br Med J (Clin Res Ed) (1986) 1.83

Epitope mapping of the human immunodeficiency virus type 1 gp120 with monoclonal antibodies. J Virol (1988) 1.82

Family studies in RA - the importance of HLA-DR4 and of genes for autoimmune thyroid disease. J Rheumatol (1983) 1.82

Breast cancer among women in their forties: toward a reasonable research agenda. J Natl Cancer Inst (1994) 1.76

Patterns of exon deletions in Duchenne and Becker muscular dystrophy. Hum Genet (1988) 1.73

Isolation and growth of a Pseudomonas species that utilizes cyanide as a source of nitrogen. J Gen Microbiol (1983) 1.73

Studies on the formation of transfer ribonucleic acid-ribosome complexes. XXIV. Effects of antibiotics on binding of aminoacyl-oligonucleotides to ribosomes. J Biol Chem (1973) 1.69

Active immunotherapy used alone for maintenance of patients with acute myeloid leukaemia. Br Med J (1973) 1.67

Mutations in the PAX3 gene causing Waardenburg syndrome type 1 and type 2. Nat Genet (1993) 1.67

Pseudo-achondrogenesis with fractures. Clin Genet (1972) 1.66

Achondroplasia and thanatophoric dwarfism in the newborn. Clin Genet (1971) 1.65

Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits. Nat Med (1999) 1.64

Leukaemia antigens and immunity in man. Nature (1973) 1.63

A clinical study of type 1 neurofibromatosis in north west England. J Med Genet (1999) 1.62

A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling. J Med Genet (1992) 1.62

The effect of hospital volume on mortality and resource use after radical prostatectomy. J Urol (2000) 1.60

Clinical significance of "cannibalism" in urinary cytology of bladder cancer. Acta Cytol (1998) 1.59

Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci U S A (1992) 1.58

Is radiation therapy a preferred alternative to surgery for squamous cell carcinoma of the base of tongue? J Clin Oncol (2000) 1.56

Effects of counseling for late stage cancer patients. Cancer (1982) 1.55

Confidential inquiry into families with two siblings with cystic fibrosis. Arch Dis Child (1997) 1.54

Unusual fetal malformations after antiemetics in early pregnancy. Br Med J (1978) 1.54

High-dose cisplatin and dacarbazine in the treatment of metastatic melanoma. J Natl Cancer Inst (1990) 1.51

The complete nucleotide sequence of the major adult beta globin gene of Xenopus laevis. J Biol Chem (1983) 1.50

Influence of oral creatine supplementation of muscle torque during repeated bouts of maximal voluntary exercise in man. Clin Sci (Lond) (1993) 1.50

Strong association between idiopathic membranous nephropathy and HLA-DRW3. Lancet (1979) 1.50

Cyclooxygenase-2 gene expression in human breast cancer. Int J Oncol (1997) 1.49

THE CIRCULATORY RESPONSES TO HYPERTHERMIA INDUCED BY RADIANT HEAT. J Clin Invest (1949) 1.48

A rare lymphoepithelial cyst of the pancreas. Am J Clin Pathol (1992) 1.47

Attitudes of patients after "genetic" termination of pregnancy. Br Med J (Clin Res Ed) (1981) 1.47

A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods (1999) 1.46

Mexican-American and Anglo-American attitudes toward organ donation. Transplant Proc (1988) 1.45

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group. Am J Epidemiol (1992) 1.44

T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol (2001) 1.43

Giant cyst of the seminal vesicle with renal agenesis. AJR Am J Roentgenol (1987) 1.43

Type 2 neurofibromatosis: the need for supraregional care? J Laryngol Otol (1993) 1.42

Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis (1995) 1.41

Electrical property sensing biopsy needle for prostate cancer detection. Prostate (2013) 1.39

States' use of transfer of custody as a requirement for providing services to emotionally disturbed children. Hosp Community Psychiatry (1991) 1.39

A memorial tribute to Edward L. Bortz, M.D. J Am Geriatr Soc (1970) 1.38

Comparison of amniotic-fluid and maternal serum alpha-fetoprotein levels in the early antenatal diagnosis of spina bifida and anencephaly. Lancet (1974) 1.37

Assignment of the locus for Waardenburg syndrome type I to human chromosome 2q37 and possible homology to the Splotch mouse. Am J Hum Genet (1990) 1.37

GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis (2010) 1.35

Adolescent suicidal behaviours: a population-based study of risk. Psychol Med (1997) 1.33

Identification of a contaminating Mycobacterium tuberculosis strain with a transposition of an IS6110 insertion element resulting in an altered spoligotype. J Clin Microbiol (2001) 1.30

Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases. Leukemia (2003) 1.28

Neural tube defect recurrence after 'partial' vitamin supplementation. J Med Genet (1989) 1.27

Partial trisomy 14q-- and pseudoxanthoma elasticum. Clin Genet (1973) 1.27

The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP. J Med Genet (1997) 1.26

commissureless controls growth cone guidance across the CNS midline in Drosophila and encodes a novel membrane protein. Neuron (1996) 1.26

Assembly mechanism of the oligomeric streptolysin O pore: the early membrane lesion is lined by a free edge of the lipid membrane and is extended gradually during oligomerization. EMBO J (1998) 1.26